The up-regulated profile of serum IL-1β, IL-6, TNF-α, and IL-8 levels in IC/BPS patients might potentially have a prognostic role and/or serve as a tool in choosing the proper therapeutic regimen for treatment. The gene discussed is CXCL8; the disease is Bartsocas-Papas syndrome 1.